(Q45912062)

English

Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.

scientific article published on 23 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

8

object named as

David H Coy

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

author name string

Cheguo Tsai

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Juliana S Leslie

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Laura G Franko-Tobin

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Monica C Prasnal

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Tong Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

L Vienna Mackey

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Joseph A Fuselier

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Mingqiu Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Changyuan Yu

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Lichun Sun

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

publication date

23 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Archives of Gynecology and Obstetrics

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

288

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

393-400

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Notch and cancer: best to avoid the ups and downs.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Notch tumor suppressor function

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Notch and cancer: a double-edged sword

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Valproic acid induces Notch1 signaling in small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Somatostatin receptor-targeted anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture.

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Posttranslational regulation of BCL2 levels in cerebellar granule cells: A mechanism of neuronal survival

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

AKT involvement in cisplatin chemoresistance of human uterine cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-2762-7

21 January 2018

Identifiers

10.1007/S00404-013-2762-7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

Dimensions Publication ID

0 references

release_2kfyyrsquzebfjdlejyuyjs76u

1 reference

https://api.fatcat.wiki/v0/release/2kfyyrsquzebfjdlejyuyjs76u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/23435724

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45912062&oldid=2207450414"